Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...
HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...
5h
AZoLifeSciences on MSNResearchers Uncover Genomic Drivers Behind Aggressive Breast CancerBreast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...
A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use in Thailand.[1,2,3] ...
Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.
NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...
Prospective study on abemaciclib-induced interstitial lung disease in metastatic breast cancer reveals a 7.4% incidence rate.
Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...
The selective oral CDK4/6 inhibitor lerociclib (GB491) combined with fulvestrant (Faslodex) provided superior progression-free survival (PFS) and tolerability in patients with hormone receptor ...
If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.
The immunotherapy used in the trial was nivolumab ( Opdivo ), a drug delivered intravenously that works by disabling a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results